India Israel South Africa city Tel Aviv covid-19 vaccine infection India Israel South Africa city Tel Aviv

South African variant can 'break through' Pfizer Covid vaccine: Israeli study

www.livemint.com

South Africa can "break through" Pfizer/BioNTech's Covid-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer reviewed.The study, released on Saturday, compared almost 400 people who had tested positive for Covid-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease.

It matched age and gender, among other characteristics.The South African variant, B.1.351, was found to make up about 1% of all the Covid-19 cases across all the people studied, according to the study by Tel Aviv University and Israel's largest healthcare provider, Clalit.But among patients who had.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News